|
Volumn 116, Issue 4, 2005, Pages 931-933
|
β-blockers and anaphylaxis: Are the risks overstated? [6] (multiple letters)
a b c d e f g h |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENALIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CONTRAST MEDIUM;
VENOM;
ANAPHYLAXIS;
ATHEROSCLEROSIS;
BRADYCARDIA;
BRAIN HEMORRHAGE;
CONGESTIVE HEART FAILURE;
DISEASE SEVERITY;
DRUG MEGADOSE;
ESSENTIAL TREMOR;
FATALITY;
HEART VENTRICLE ARRHYTHMIA;
HEART VENTRICLE FIBRILLATION;
HUMAN;
HYMENOPTERA;
HYPERTENSION;
HYPOTENSION;
IMMUNOTHERAPY;
ISCHEMIC HEART DISEASE;
LETTER;
PRIORITY JOURNAL;
RESUSCITATION;
RISK FACTOR;
STATISTICAL SIGNIFICANCE;
TREATMENT CONTRAINDICATION;
TREATMENT OUTCOME;
VASCULAR HEADACHE;
|
EID: 25844503085
PISSN: 00916749
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaci.2005.06.019 Document Type: Letter |
Times cited : (12)
|
References (8)
|